DE GIGLIO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 3.685
AS - Asia 2.234
EU - Europa 1.329
SA - Sud America 335
AF - Africa 141
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.730
Nazione #
US - Stati Uniti d'America 3.609
SG - Singapore 759
IT - Italia 483
HK - Hong Kong 326
CN - Cina 317
BR - Brasile 259
VN - Vietnam 254
IN - India 209
DE - Germania 166
SE - Svezia 132
FI - Finlandia 103
FR - Francia 81
RU - Federazione Russa 77
GB - Regno Unito 62
BD - Bangladesh 47
CA - Canada 47
JP - Giappone 44
MA - Marocco 44
NL - Olanda 42
ZA - Sudafrica 41
AR - Argentina 34
TH - Thailandia 34
ID - Indonesia 33
IQ - Iraq 33
TR - Turchia 33
IE - Irlanda 29
BG - Bulgaria 26
RO - Romania 22
UA - Ucraina 22
IL - Israele 15
UZ - Uzbekistan 15
EG - Egitto 14
MX - Messico 14
VE - Venezuela 14
ES - Italia 13
PK - Pakistan 13
BE - Belgio 12
PH - Filippine 12
AT - Austria 10
IR - Iran 9
KR - Corea 9
SA - Arabia Saudita 9
CO - Colombia 8
JO - Giordania 8
CZ - Repubblica Ceca 7
NG - Nigeria 7
CI - Costa d'Avorio 6
EC - Ecuador 6
KZ - Kazakistan 6
PL - Polonia 6
AZ - Azerbaigian 5
CL - Cile 5
LB - Libano 5
LT - Lituania 5
NP - Nepal 5
OM - Oman 5
PS - Palestinian Territory 5
TG - Togo 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AU - Australia 4
ET - Etiopia 4
GT - Guatemala 4
JM - Giamaica 4
KE - Kenya 4
MY - Malesia 4
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
DK - Danimarca 3
HU - Ungheria 3
KG - Kirghizistan 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AM - Armenia 2
CR - Costa Rica 2
CY - Cipro 2
GR - Grecia 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
PT - Portogallo 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
Totale 7.722
Città #
Fairfield 400
Singapore 386
Ashburn 356
Hong Kong 299
San Jose 291
Chandler 208
Woodbridge 145
Seattle 140
Rome 137
Wilmington 133
Los Angeles 128
Houston 120
Cambridge 105
Ho Chi Minh City 75
New York 69
Princeton 68
Hanoi 65
Beijing 60
Santa Clara 60
The Dalles 56
Dallas 51
Lauterbourg 50
Munich 50
Ann Arbor 49
Frankfurt am Main 48
Buffalo 46
Helsinki 45
Hillsboro 44
San Paolo di Civitate 43
Cosenza 38
Boston 37
Council Bluffs 37
Tokyo 37
Lawrence 34
Plano 34
San Diego 34
Casablanca 33
Dearborn 32
Milan 30
Johannesburg 29
Millbury 28
Dublin 27
Redondo Beach 27
Sofia 26
Turku 26
Jakarta 24
Chicago 23
Moscow 22
Norwalk 22
Stockholm 20
Bangkok 19
Nuremberg 19
London 17
São Paulo 17
Falkenstein 16
Des Moines 14
Latina 14
Naples 14
Toronto 14
Lappeenranta 13
Tashkent 13
Bengaluru 12
Brussels 12
Amsterdam 11
Andover 11
Baghdad 11
Elk Grove Village 11
Rio de Janeiro 11
Biên Hòa 10
Brooklyn 10
Guangzhou 10
Haiphong 10
Queens 10
Tampa 10
Federal 9
Istanbul 9
Phoenix 9
Amman 8
Atlanta 8
Belo Horizonte 8
Carmiano 8
Da Nang 8
Montreal 8
Orem 8
Ottawa 8
Phra Nakhon Si Ayutthaya 8
Salt Lake City 8
Shanghai 8
Ankara 7
Denver 7
Enschede 7
Redwood City 7
San Mateo 7
Abidjan 6
Boardman 6
Brasília 6
Cape Town 6
Changsha 6
Dhaka 6
Florence 6
Totale 4.848
Nome #
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 265
Cesarean section in women with MS: a choice or a need? 185
Cesarean section in women with MS: A choice or a need? 184
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study 170
Attrv in lazio-italy: A high-prevalence region in a non-endemic country 166
A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis 166
The role of fMRI in the assessment of neuroplasticity in MS: a systematic review 161
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis 157
Listeria monocytogenes-Induced rhombencephalitis in a patient with multiple sclerosis treated with dimethyl fumarate 152
Effect on cognition of estroprogestins combined with Interferon Beta in multiple sclerosis: analysis of secondary outcomes from a randomised controlled trial 151
Role of cerebellar dentate functional connectivity in balance deficits in patients with multiple sclerosis 147
Premorbid functional reserve modulates the effect of rehabilitation in multiple sclerosis 144
Relation between functional connectivity and disability in multiple sclerosis. a non-linear model 143
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study 141
Neuroimaging techniques to assess inflammation in multiple sclerosis 138
Dentate nucleus connectivity in adult patients with multiple sclerosis: functional changes at rest and correlation with clinical features 135
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation 134
Oral contraceptives combined with interferon β in multiple sclerosis 128
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis. 126
Relationship between prolactin plasma levels and white matter volume in women with multiple sclerosis 126
Dalfampridine improves cognition impairment in multiple sclerosis (MS): results from a randomised, double-blind, placebo-controlled trial. 125
Lesion symptom map of cognitive–postural interference in multiple sclerosis 124
Multiple sclerosis: Changes in thalamic resting-State functional connectivity induced by A homebased cognitive rehabilitation program 123
A low-cost cognitive rehabilitation with a commercial video game improves sustained attention and executive functions in multiple sclerosis: A pilot study 123
Frailty and relapse activity in multiple sclerosis: A longitudinal observation 122
‘Posture second’ strategy predicts disability progression in multiple sclerosis 121
The added value of spinal cord lesions to disability accrual in multiple sclerosis 120
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience 120
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial 119
Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis 114
Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients 114
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis 114
Potential rotective role of pregnancy and breastfeeding in delaying onset symptoms related to multiple sclerosis 113
Mathematical modelling characterises fatigability as a distinct phenomenon in patients with multiple sclerosis 112
The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray) 111
Effect of dalfampridine on information processing speed impairment in multiple sclerosis 109
Investigating the phenomenon of "cognitive-motor interference" in multiple sclerosis by means of dual-task posturography 107
Multi-scale resting state functional reorganization in response to multiple sclerosis damage 107
Advances in preventing adverse events during monoclonal antibody management of multiple sclerosis 107
Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy 106
Mood and coping in clinically isolated syndrome and multiple sclerosis. 103
A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta 100
A matter of atrophy: differential impact of brain and spine volume loss on disability worsening in MS 99
Different substrate for fatigue and depression in multiple sclerosis: role of basal ganglia atrophy 98
Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial 96
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: A prospective observational multicentric study 96
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs 94
Task-dependent deterioration of balance underpinning cognitive-postural interference in MS. 94
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study 93
Corpus callosum microstructural changes associated with Kawashima Nintendo Brain Training in patients with multiple sclerosis 93
Atypical motor neuron disease with bent spine clinical onset and long survival carrying C9orf72 expansion 93
Multiple sclerosis treatment and melanoma development 91
Treatment of multiple sclerosis-related fatigue: pharmacological and non-pharmacological approaches 89
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers. an Italian Association of Myology survey of the acute phase 88
Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis 87
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online 79
Listeria Monocytogenes-Induced Rhombencephalitis-A Paradoxical Disease of Immunocompetent Patients-Reply 78
Combining MRI activity with markers of myelin damage in clinically isolated syndrome suggestive of multiple sclerosis 75
Relationship between regional corpus callous atrophy and Paced Auditory Serial Addition test in multiple sclerosis 64
null 62
null 62
Natalizumab discontinuation and disease restart in pregnancy: A case series 61
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 60
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab. iI maternal risks 59
null 59
Diagnostic Performance of Three Serological Assays in Myasthenia Gravis: A Prospective Multicentre Study 58
null 56
null 55
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis 55
null 53
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124. 46
null 46
null 36
Natalizumab discontinuation and disease restart in pregnancy: a case series. Acta Neurol Scand. 2015 Jan 18. doi: 10.1111/ane.12364. [Epub ahead of print] 28
null 27
null 27
null 26
null 24
null 16
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study 13
Mood and coping in clinically isolated syndrome and multiple sclerosis 5
null 3
Totale 8.077
Categoria #
all - tutte 21.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 53 43
2021/2022775 23 23 54 33 104 58 15 59 55 48 190 113
2022/2023651 121 118 32 60 93 52 19 50 68 6 20 12
2023/2024410 25 42 15 32 31 75 15 31 3 53 55 33
2024/20251.587 38 27 44 79 79 77 115 97 245 132 132 522
2025/20263.141 337 147 280 288 393 193 432 168 321 404 178 0
Totale 8.077